Impact of the Relaxation Response Resiliency Program on Patients With Atrial Fibrillation

Completed · Not applicable

Conditions studied: Atrial Fibrillation, Stress, Quality of Life, Anxiety, Depression, Hostility

In brief

The purpose of this study is to determine if an eight week multimodal Relaxation Response Resiliency Program (3RP) intervention can effectively improve symptom severity, frequency and quality of life (Q.O.L) in atrial fibrillation (AF) patients. This will be measured by a reduction in AF symptom score, perceived stress, anxiety, hostility and depression.

Key facts

Study ID

NCT02634697

Run by

Massachusetts General Hospital

People needed

15

Starts

2015-04-01

Expected to finish

2017-01-09

Last updated by the study team

2020-02-28

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age: 18-90 years
• Diagnosed with documented recurrent symptomatic paroxysmal atrial fibrillation
• Currently on stable medical therapy for AF and willing to continue on the same treatment regimen for 8 weeks while participating in the study.
• No current or prior practice of yoga, meditation, guided imagery or other techniques that elicit relaxation response (RR).
• Able to provide informed consent and to understand written and spoken English.

You may not qualify if…

• End Stage renal failure or heart failure, severe unstable medical or psychiatric disease
• Patients deemed unable to complete protocol due to cognitive or other reasons.
• Patients on psychoactive medications will have eligibility determined by the PI or MD co-investigator on a case-by-case basis, and will be admitted to the study if medication is deemed stable

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.